R450,00
Anti-inflammatory, Immunity Modulator, Pulmonary & Vascular Support – Gut Health & Motility, Neuroprotective Effects.
R450,00
10 in stock
VIP is a lab-made synthetic 28-amino-acid peptide hormone – an exact copy of the natural neuropeptide produced in the gut, brain, lungs, and other tissues. Discovered in 1970 as a potent vasodilator (hence the name), it belongs to the secretin/glucagon family and acts as both a neurotransmitter and immunomodulator.
Think of VIP as your body’s ‘relax and protect’ signal – it widens blood vessels, calms inflammation, and supports multiple systems without overstimulating them.
How it works:
-Triggers vasodilation, smooth-muscle relaxation, anti-inflammatory cytokine shifts, and immune balance while protecting tissues (e.g., lungs, gut, brain).
In short: It promotes relaxation, repair, and balance across multiple systems – especially lungs, gut, and immune responses.
VIP shows good short-term tolerability in trials, but systemic effects can occur.
In human studies: Mild and transient for most.
– Flushing, headache, nausea, or mild hypotension (due to vasodilation).
– Nasal irritation (with spray forms).
– Rare: Allergic responses or exaggerated vasodilation.
For Researchers Only. Not for Human or Vetinerary Consumption.
Method of Administration: Subcutaneous into fatty tissue. Researchers should be aware of avoiding injecting this peptide into veins.
Reconstitution: 2ml Bac water into single vial. See Reconstitution Guide
Dose: Researchers will recommend 200mcg daily. 100mcg in morning/100mcg at night. Therefore draw 4 units or 0.04 ml. Not 40 units. Tiny amount, similar to KPV.
Use peptide calculator for alternative dosage.
Course: This will last 25 days.
Cycling: 8 weeks on, 8 weeks off.
Tip: Reconstitute with bacteriostatic water; store in fridge. Use insulin syringes and sterile technique.
Human data is from small trials and exploratory studies (pulmonary, headache, GI); larger approvals stalled.
1. Liv Hospital overview (Feb 2026): Not FDA-approved; investigational; mechanism via VPAC1/VPAC2; used in research for vasodilation and immunomodulation.
2. Iwasaki et al. (2019 PMC, referenced 2026): Comprehensive review – VIP physiology in GI tract (vasodilation, secretion, motility, immune regulation); multiple effects on gut barrier and inflammation.
3. ClinicalTrials.gov NCT03989817 (ongoing/referenced 2026): Long-lasting VIP infusion effects on headache, cranial hemodynamics, and autonomic symptoms in healthy volunteers.
4. Strive Pharmacy research page (2026): Broad roles (vasodilation, anti-inflammatory); investigational nasal spray forms in research.5. Petkov et al. (2003 PMC): VIP as potential new drug for primary pulmonary hypertension – potent vasodilator effects in models.
6. Hou et al. (2022 Frontiers): Therapeutic potential of VIP/VPAC2 agonists in type 2 diabetes – glucose-dependent insulin secretion.
7. Youssef et al. (2022 PMC): IV Aviptadil (synthetic VIP) in critical COVID-19 respiratory failure – 60-day RCT results; fast-track designation.
Collagen Production, Skin Rejuvenation, Antioxidant Protection, Anti-Inflammatory, Rapid Healing, Tissue Repair.
R1 400,00
Cartilage Protection, Joint Health, Osteoarthritis Progression, Connective Tissue Repair, Anti-Inflammatory & Anti-Aging effects
R550,00
The ‘Love Peptide’, Social Bonding, Trust, Emotional Connection, Anxiety Reduction, Mild Pain Modulation.
R450,00
Neuroprotection, Oxidative Stress, Toxicity, Inflammation, Metabolic Health, Insulin Sensitivity, Cardiovascular Health.
R910,00
The Beauty Peptide, Skin Rejuvenation, Wound Healing, Hair and Nail Growth, Anti-Aging, Skin Rejuvenation, Wrinkle reduction, Skin Elasticity, Anti-Oxidant, Scar Reduction, Inflammation, Hair Growth.
R380,00
Targeted Visceral Fat Reduction, Improved Body Composition, Liver Fat Reduction, Enhanced Metabolism, Cognitive Enhancement.
R1 150,00